VIRIDIAN THERAPEUTICS INC

24 sie 2026, 19:26 UTC

Viridian Therapeutics Inc is declining during Monday's session, continuing a trend of lower performance over the past three days amid geopolitical and inflation concerns.

21 sie 2026, 23:21 UTC

Viridian Therapeutics Inc. shares advanced in after-market trading, continuing a strong one-month performance and remaining above the 20-day moving average.

20 sie 2026, 22:56 UTC

Viridian Therapeutics Inc. shares declined in after-hours trading, reflecting broader market trends amid concerns about consumer spending and inflation pressures.

19 sie 2026, 23:01 UTC

Viridian Therapeutics Inc is trading higher in after-market hours, reflecting positive market sentiment amid broader gains and strong performance in cryptocurrency values.

17 sie 2026, 20:06 UTC

Viridian Therapeutics Inc shares rose significantly since Friday's close, reaching a peak increase in late morning trading, though no specific news was identified.

14 sie 2026, 19:56 UTC

Viridian Therapeutics is trading higher, recovering from an earlier dip, as broader market sentiment reacts to a surprise decline in U.S. retail sales.

13 sie 2026, 19:56 UTC

Viridian Therapeutics Inc shares declined again, marking five consecutive lower closes, amid broader weakness in the biotechnology sector and rising unemployment claims.

11 sie 2026, 19:46 UTC

Viridian Therapeutics Inc shares are lower today amid broader market declines following a weak jobs report, influencing expectations for Federal Reserve policy.

7 sie 2026, 20:05 UTC

Viridian Therapeutics shares rise after Truist Securities raised its price target to $39. The ARK Genomic Revolution ETF's gains may also influence the stock.

6 sie 2026, 21:02 UTC

Viridian Therapeutics Inc is trading higher in after-market hours, extending five consecutive sessions of gains amid broader market resilience and positive economic data.

5 sie 2026, 23:02 UTC

Viridian Therapeutics Inc shares declined in after-market trading, sharply lower since Wednesday's close, despite finishing higher in the previous three sessions.

4 sie 2026, 21:02 UTC

Viridian Therapeutics shares are lower in after-hours trading, declining from earlier session highs despite being above the 20-day moving average.

3 sie 2026, 23:01 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, reaching their lowest point despite a prior period of stability. No specific news was identified.

31 lip 2026, 20:02 UTC

Viridian Therapeutics Inc's shares are lower today, breaking a trend of higher closes. Broader market factors, including rising Treasury yields, may be influencing this shift.

30 lip 2026, 23:01 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, following earlier stability. Broader market uncertainty over the Federal Reserve's rate decision persists.

29 lip 2026, 23:56 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. Broader market uncertainty persists.

28 lip 2026, 21:02 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, reversing an initial uptick amid cautious broader market sentiment and declines in technology shares.

27 lip 2026, 19:26 UTC

Viridian Therapeutics Inc is trading higher, maintaining strength since Friday's close and reflecting positive momentum near the upper end of its one-month trading range.

24 lip 2026, 17:36 UTC

Viridian Therapeutics shares are higher since Thursday's close, recovering from earlier lows. Broader market sentiment improved amid declining crude oil prices.

22 lip 2026, 19:26 UTC

Viridian Therapeutics Inc is trading higher during Wednesday's session, recovering from earlier lows despite the broader market's mixed performance.

21 lip 2026, 19:51 UTC

Viridian Therapeutics Inc shares are trading higher, reflecting strong intraday performance. The move aligns with positive sentiment in the biotechnology sector.

20 lip 2026, 19:01 UTC

Viridian Therapeutics Inc is advancing in Monday's session, despite earlier pullback. No specific company news was identified to explain the price movement.